BI-RADS Classification of Breast Color Doppler Ultrasound

I just saw a breast color Doppler ultrasound in an outpatient clinic of another hospital, breast nodule BRADS 4B, the patient was nervous, and then I gave him a popular science. The BI-RADS classification of breast color Doppler ultrasound is used to assess the condition of breast lesions, which is mainly divided into the following categories: Category 0 The assessment is incomplete and needs to be further assessed in combination with other examinations. For example, the ultrasound examination may not be able to accurately judge because the breast glands are too dense, and other imaging examinations such as breast magnetic resonance imaging (MRI) are often needed. Class 1 negative, no abnormal changes in breast examination, that is, normal breast, routine physical examination is OK, it is recommended to review breast ultrasound once a year. Two types of benign lesions can be basically determined to be benign, such as simple cysts, lymph nodes in the breast (also normal), breast prosthesis implantation, etc. Are often classified as such, and it is generally recommended to review breast ultrasound every 6-12 months. Three types may be benign lesions, but there is less than 2% of the possibility of malignancy, such as breast fibroadenoma and other common benign tumors in this category, usually recommended short-term follow-up review, generally 3-6 months to review a breast ultrasound, to observe whether the lesions have changed. Class 4 is subdivided into Class 4A, Class 4B and Class 4C: Class 4A: The possibility of malignancy is between 2% and 10%, and biopsy or short-term close follow-up can be considered, such as 3-month follow-up of breast ultrasound to observe the changes. -Category B: The possibility of malignancy is between 10% and 50%. Biopsy is generally recommended to determine the nature of the lesion, such as breast biopsy. Category 4C: The possibility of malignancy is between 50% and 95%. Malignancy is highly suspected. Biopsy and further evaluation of treatment options are usually required as soon as possible. Five types of highly suspected malignant lesions, the possibility of malignancy is more than 95%, clinical will generally arrange further treatment measures such as surgery as soon as possible according to the specific situation, and combined with biopsy pathology to confirm the diagnosis. Six types have been confirmed to be malignant by biopsy, but relevant imaging examinations are still being carried out to assess the extent of lesions and metastasis, so as to formulate follow-up comprehensive treatment programs such as surgery, chemotherapy and radiotherapy.